Groundbreaking New Drug Trial Offers Hope to Alzheimer’s Sufferers

Alzheimer s disease affects a significant portion of the senior population, and it impacts the lives of loved ones and caregivers, as well. This makes it one of the primary issues facing seniors today. Unfortunately, there is no cure for the disease, though it is treatable, making hope a valuable commodity. Thankfully, there has been some recent good news in the fight against Alzheimer s. According to a recent report from CBS News (http://www.cbsnews.com/news/new-trial-to-treat-alzheimers-seen-as-game-changing/), a new drug trial has given doctors, patients and caregivers reason to feel good about progress in the battle with this terrible disease. Known as the “A4 Study” (http://a4study.org), this encouraging trial has been testing whether a drug called Solanezumab is able to slow the progress – or even prevent – Alzheimer s disease. The study, which is taking place internationally in 60 different hospitals, is seeking patients who have not yet developed memory loss, but who h
http://blog.alwaysbestcare.com/groundbreaking-new-drug-trial-offers-hope-to-alzheimers-sufferers/